ALC:NYSE
Alcon AG
74,43 USD
arrow_downward
-0,12%(-0,090) 1D
20-ноя., 11:42:52 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
74,16 USD
High
75,04 USD
Low
74,10 USD
Mkt. cap
31,26 млд
Avg. vol.
2,43 млн
Volume
856,22 миң
52-wk high
87,64 USD
52-wk low
61,84 USD
Beta
0,87
Shares outstanding
480,40 млн
No. of employees
25 миң
Open
74,16 USD
High
75,04 USD
Low
74,10 USD
Mkt. cap
31,26 млд
Avg. vol.
2,43 млн
Volume
856,22 миң
52-wk high
87,64 USD
52-wk low
61,84 USD
Beta
0,87
Shares outstanding
480,40 млн
No. of employees
25 миң
News stories
From web sources and news partners
ad-hoc-news.de
·
41 мүнөт мурун
Alcon stock: Pershing Square takes a $954 million stake
TradingView
·
9 саат мурун
Alcon Inc. Stock 12‑Month Price Target Raised to $86.4, Implies 16% Upside
Yahoo Finance
·
19 саат мурун
Why Pershing Square Is Betting Big on Alcon Stock
Zacks
·
2 күн мурун
What Drove Glaukos Stock's 48% Rally Since the End of September?
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25 миң
Founded1945
HeadquartersЖенева, Женева, Швейцария
SectorHealth Care
IndustryMedical device
Websitealcon.com